Cargando…
Tissue factor pathway inhibitor-2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix
Tissue factor pathway inhibitor-2 (TFPI-2) is a promising candidate as a serum biomarker of ovarian clear cell carcinoma (OCCC), a lethal histological subtype of epithelial ovarian cancer (EOC). TFPI-2 is a secreted serine protease inhibitor that suppresses cancer progression through the inhibition...
Autores principales: | Ota, Yukihide, Koizume, Shiro, Nakamura, Yoshiyasu, Yoshihara, Mitsuyo, Takahashi, Tomoko, Sato, Shinya, Myoba, Shohei, Ohtake, Norihisa, Kato, Hisamori, Yokose, Tomoyuki, Miyagi, Etsuko, Miyagi, Yohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859994/ https://www.ncbi.nlm.nih.gov/pubmed/33650653 http://dx.doi.org/10.3892/or.2021.7944 |
Ejemplares similares
-
Cancer cell‐derived CD69 induced under lipid and oxygen starvation promotes ovarian cancer progression through fibronectin
por: Koizume, Shiro, et al.
Publicado: (2023) -
A practical spatial analysis method for elucidating the biological mechanisms of cancers with abdominal dissemination in vivo
por: Ota, Yukihide, et al.
Publicado: (2022) -
Annexin A4 Is Involved in Proliferation, Chemo-Resistance and Migration and Invasion in Ovarian Clear Cell Adenocarcinoma Cells
por: Mogami, Tae, et al.
Publicado: (2013) -
Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer
por: Koizume, Shiro, et al.
Publicado: (2015) -
Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications
por: Koizume, Shiro, et al.
Publicado: (2022)